NEWCAN BIOTECH LIMITED

NewCan Biotech Limited was established in 2021 and is primarily engaged in the research, development, production, and sales of phosphite amide monomers, nucleosides, nucleotides and their modifiers, sugars, new generation of antiviral and antitumor drug intermediates. Our products are mainly used in new drug research and development, biosynthesis, PCR amplification, gene sequencing, diagnostic reagent production, life science research and other fields. The company has complete experimental, analysis and production facilities, equipped with professional R&D and production teams, and has the production capacity from small-scale test, pilot test to industrial scale. We have established stable cooperative relations with many domestic and foreign biomedical technology companies with high-quality product quality, service and competitive price. In order to better serve our customers, we are constantly introducing new products in the field of nucleosides and nucleotides.